Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities

Zhang R, Song Y, Su X.

J Alzheimers Dis. 2023;94(s1):S367-S386. doi: 10.3233/JAD-220809.

Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease

Yamali C, Donmez S.

Mini Rev Med Chem. 2023;23(7):869-880. doi: 10.2174/1389557523666221201145141.

NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease

Painuli S, Semwal P, Zam W, Taheri Y, Ezzat SM, Zuo P, Li L, Kumar D, Sharifi-Rad J, Cruz-Martins N.

Comb Chem High Throughput Screen. 2023;26(12):2099-2112. doi: 10.2174/1386207325666220428112541.

Role of Polyphenols in Alleviating Alzheimer's Disease: A Review

William Raja TR, Duraipandiyan V, Ignacimuthu S, Janakiraman U, Packiam SM.

Curr Med Chem. 2023;30(35):4032-4047. doi: 10.2174/0929867330666221202152540.

Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective

Rajah Kumaran K, Yunusa S, Perimal E, Wahab H, Müller CP, Hassan Z.

J Alzheimers Dis. 2023;91(2):507-530. doi: 10.3233/JAD-220666.

Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial

Noguchi-Shinohara M, Hamaguchi T, Sakai K, Komatsu J, Iwasa K, Horimoto M, Nakamura H, Yamada M, Ono K.

J Alzheimers Dis. 2023;91(2):805-814. doi: 10.3233/JAD-220953.

Mutual Prodrugs - Codrugs

Nudelman A.

Curr Med Chem. 2023;30(38):4283-4339. doi: 10.2174/0929867330666221209102650.

A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease

Patel A, Shah D, Patel Y, Patel S, Mehta M, Bambharoliya T.

Curr Drug Targets. 2023;24(3):225-246. doi: 10.2174/1389450124666221213114500.

Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs

Alan E, Kerry Z, Sevin G.

Fundam Clin Pharmacol. 2023 Jun;37(3):397-427. doi: 10.1111/fcp.12861. Epub 2023 Jan 13.

Moving the Needle on Alzheimer's Disease with an Anti-Oligomer Antibody

Gandy S, Ehrlich ME.

N Engl J Med. 2023 Jan 5;388(1):80-81. doi: 10.1056/NEJMe2214981.

Neural stem/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis

Zhou Z, Shi B, Xu Y, Zhang J, Liu X, Zhou X, Feng B, Ma J, Cui H.

Stem Cell Res Ther. 2023 Jan 5;14(1):3. doi: 10.1186/s13287-022-03231-1.

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target

Rusek M, Smith J, El-Khatib K, Aikins K, Czuczwar SJ, Pluta R.

Int J Mol Sci. 2023 Jan 3;24(1):864. doi: 10.3390/ijms24010864.

Pharmacogenetics of anxiety and depression in Alzheimer's disease

Cacabelos R, Carril JC, Corzo L, Pego R, Cacabelos N, Alcaraz M, Muñiz A, Martínez-Iglesias O, Naidoo V.

Pharmacogenomics. 2023 Jan;24(1):27-57. doi: 10.2217/pgs-2022-0137. Epub 2023 Jan 11.

Impact of nanoparticles on amyloid β-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review

Chakraborty A, Mohapatra SS, Barik S, Roy I, Gupta B, Biswas A.

Biosci Rep. 2023 Feb 27;43(2):BSR20220324. doi: 10.1042/BSR20220324.

The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease

Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.

Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias